高级检索
当前位置: 首页 > 详情页

Potential Advantages of Bioactive Compounds Extracted From Traditional Chinese Medicine to Inhibit Bone Destructions in Rheumatoid Arthritis.

文献详情

资源类型:
WOS体系:
Pubmed体系:

收录情况: ◇ SCIE

机构: [1]Shanghai Innovation Center of TCM Health Service, Shanghai University of Traditional Chinese Medicine, Shanghai, China, [2]Institute of Basic Research in Clinical Medicine, China Academy of Chinese Medical Sciences, Beijing, China, [3]The SecondClinical Medical College, Guangzhou University of Chinese Medicine, Guangzhou, China, [4]College of Medicine, SouthwestJiaotong University, Chengdu, China, [5]School of Chinese Medicine, Law Sau Fai Institute for Advancing TranslationalMedicine in Bone and Joint Diseases, Hong Kong Baptist University, Hong Kong, Hong Kong
出处:
ISSN:

关键词: bone destruction rheumatoid arthritis traditional Chinese medicine bioactive compounds bone metabolism

摘要:
Bone destruction is an important pathological feature of rheumatoid arthritis (RA), which finally leads to the serious decline of life quality in RA patients. Bone metabolism imbalance is the principal factor of bone destruction in RA, which is manifested by excessive osteoclast-mediated bone resorption and inadequate osteoblast-mediated bone formation. Although current drugs alleviate the process of bone destruction to a certain extent, there are still many deficiencies. Recent studies have shown that traditional Chinese medicine (TCM) could effectively suppress bone destruction of RA. Some bioactive compounds from TCM have shown good effect on inhibiting osteoclast differentiation and promoting osteoblast proliferation. This article reviews the research progress of bioactive compounds exacted from TCM in inhibiting bone destruction of RA, so as to provide references for further clinical and scientific research. Copyright © 2020 Shi, Shu, Wang, Zhao, Lu, Lu and He.

基金:
语种:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2019]版:
大类 | 2 区 医学
小类 | 2 区 药学
最新[2025]版:
大类 | 3 区 医学
小类 | 3 区 药学
JCR分区:
出版当年[2018]版:
Q1 PHARMACOLOGY & PHARMACY
最新[2023]版:
Q1 PHARMACOLOGY & PHARMACY

影响因子: 最新[2023版] 最新五年平均 出版当年[2018版] 出版当年五年平均 出版前一年[2017版] 出版后一年[2019版]

第一作者:
第一作者机构: [1]Shanghai Innovation Center of TCM Health Service, Shanghai University of Traditional Chinese Medicine, Shanghai, China, [2]Institute of Basic Research in Clinical Medicine, China Academy of Chinese Medical Sciences, Beijing, China,
通讯作者:
通讯机构: [1]Shanghai Innovation Center of TCM Health Service, Shanghai University of Traditional Chinese Medicine, Shanghai, China, [5]School of Chinese Medicine, Law Sau Fai Institute for Advancing TranslationalMedicine in Bone and Joint Diseases, Hong Kong Baptist University, Hong Kong, Hong Kong
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:2018 今日访问量:0 总访问量:645 更新日期:2024-07-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 广东省中医院 技术支持:重庆聚合科技有限公司 地址:广州市越秀区大德路111号